Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Goodwill (2017 - 2025)

Dr Reddys Laboratories (RDY) has 3 years of Goodwill data on record, last reported at $51.6 million in Q1 2023.

  • For Q1 2023, Goodwill changed N/A year-over-year to $51.6 million; the TTM value through Mar 2023 reached $51.6 million, changed N/A, while the annual FY2023 figure was $52.9 million, N/A changed from the prior year.
  • Goodwill reached $51.6 million in Q1 2023 per RDY's latest filing, down from $62.6 million in the prior quarter.
  • Across five years, Goodwill topped out at $62.6 million in Q1 2021 and bottomed at $51.6 million in Q1 2023.
  • Average Goodwill over 3 years is $56.5 million, with a median of $55.1 million recorded in 2020.
  • The widest YoY moves for Goodwill: up 13.64% in 2021, down 13.64% in 2021.
  • A 3-year view of Goodwill shows it stood at $55.1 million in 2020, then grew by 13.64% to $62.6 million in 2021, then dropped by 17.57% to $51.6 million in 2023.
  • Per Business Quant database, its latest 3 readings for Goodwill were $51.6 million in Q1 2023, $62.6 million in Q1 2021, and $55.1 million in Q1 2020.